Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2-Reference-Cited by-同舟云学术

Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2

Published:2022-03 Issue: Volume:143 Page:94-99
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Badano María Noel^ORCID,Sabbione Florencia,Keitelman Irene,Pereson Matias^ORCID,Aloisi Natalia,Colado Ana,Ramos María Victoria,Ortiz Wilczyñski Juan Manuel^ORCID,Pozner Roberto Gabriel,Castillo Luis^ORCID,Wigdorovitz Georgina,E.de Bracco María Marta,Fink Susana,Chuit Roberto,Baré Patricia

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference11 articles.

1. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial;Al Kaabi;JAMA,2021

2. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2;Ebinger;Nat. Med.,2021

3. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2;Havervall;EBioMedicine,2021

4. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine;Krammer;N. Engl. J. Med.,2021

5. Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy;Ma;Cell Discov.,2021

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco;Scientific Reports;2024-04-03

2. Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial;BMC Medicine;2024-02-20

3. Immunogenicity and safety of inactivated SARS‐CoV‐2 vaccines in people living with HIV: A longitudinal cohort study;Journal of Medical Virology;2023-12

4. COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study;Vaccines;2023-10-30

5. Silent SARS-CoV-2 infection: seroprevalence study of SARS-CoV-2 anti- nucleocapsid IgG antibodies in Kragujevac, Serbia;Acta Virologica;2023-09-26